With the LSN Digital RESI Conference approaching quickly, Event Gold Sponsor, BioHealth Innovation (BHI), is stepping up to help lead five panels with some heavy hitters from the BioHealth Capital Region (BHCR) on June 8-10, 2020.
Great Investment Opportunities in the BioHealth Capital Region
While we adjust to a COVID-19 world, there continue to be great investment opportunities in the BioHealth Capital Region. Join BHCR CEOs as they make short introductions about themselves and companies. Join CEOs from American Gene Technologies International Inc., miRecule, Adaptive Phage, Healion Bio, KaloCyte, Emocha, Tailored Therapeutics, Inc., DEKA, and Ashvattha Therapeutics, Inc.
Raising Early Stage Capital in Difficult Times
Companies are still working to raise capital while we remain socially distant. Join us as we discuss how to best adjust and continue attracting investors to your business. Moderator, Rich Bendis, Founder, President and CEO of BioHealth Innovation, is joined by investment experts from Alexandria Venture Investments, The BioHealth Capital Fund, Boston Millennia Partners, and JP Morgan.
Collaborating for Growth in the BioHealth Capital Region
Being able to collaborate with your business partners is as important today as it ever has been. This panel demonstrates the strong collaboration taking place in the BioHealth Capital Region. Led by Jarrod Borkat, Senior Director, External Partnerships & Collaborations, Emergent BioSolutions, Inc., the panel includes experts from Children’s National Hospital, George Mason University, AstraZeneca, and Immunomic Therapeutics.
International BioHealth Companies Entering the U.S. Market
Also known as “Soft Landing”, the ability for International BioHealth Companies to be able to successfully enter the U.S. Market and grow is a constant challenge. Having a partner in the U.S. to help with this process is critical to your business. Moderator, Rich Bendis, Founder, President and CEO of BioHealth Innovation, discusses the topic with representatives from BHI, Gentian Diagnostics (Norway), Mimetas (Netherlands), and OnDosis (Sweden).
Advancing your Technology Through Non-Dilutive Grants
Keeping ownership of your company and technology, while raising growth capital, is an important topic for many entrepreneurs. Join our panel led by BioHealth Innovation Inc.’s Managing Director – Economic Development, Judy Costello, as she covers the in’s and out’s with participants who have successfully navigated these waters. Industry experts from Aperiomics, miRecule, Mimetas, SpineAlign, and TEDCO join the discussion to share their experiences.